|
Exempt Distribution- 2021-03-23
|
3
|
Resverlogix Corp.
|
Mar 24, 2021 02:46PM
|
|
Re: Reports of Exempt Distribution
|
3
|
Zenith Epigenetics
|
Feb 09, 2023 08:54AM
|
|
Re: No mention of efficacy again...
|
3
|
Resverlogix Corp.
|
Mar 27, 2019 04:16PM
|
|
Re: What population would our CD drug cover,...?
|
3
|
Resverlogix Corp.
|
Nov 27, 2019 09:25AM
|
|
Re: Our own BKC on the webcast
|
3
|
Resverlogix Corp.
|
Feb 15, 2021 12:51PM
|
|
October 24, 2023 How SARS-CoV-2 contributes to heart attacks and strokes
|
3
|
Resverlogix Corp.
|
Oct 29, 2023 08:36AM
|
|
Re: Apabetalone inhibits kidney damage in diabetes
|
3
|
Resverlogix Corp.
|
Aug 22, 2024 10:27AM
|
|
BioBoss
|
3
|
BIOASIS TECHNOLOGIES INC
|
Mar 05, 2019 09:06AM
|
|
Re: Deadlines missed? Results Late? Not really.
|
3
|
Resverlogix Corp.
|
Jan 12, 2019 05:29PM
|
|
Re: Stock price
|
3
|
Resverlogix Corp.
|
Apr 25, 2019 01:31PM
|
|
Re: Zenith Epigenetics Corp (ZEC) held the shares issued to RVX shareholders in June 2013.
|
3
|
Zenith Epigenetics
|
Apr 14, 2023 06:52AM
|
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
2
|
Resverlogix Corp.
|
Jun 14, 2020 10:56AM
|
|
Re: Collaborating with the Supreme Council of the Arab-African Economy
|
2
|
Resverlogix Corp.
|
Nov 06, 2021 09:41AM
|
|
Re: Deal Closing?
|
2
|
Resverlogix Corp.
|
May 28, 2019 03:41PM
|
|
Re: Timing of the topline data
|
2
|
Resverlogix Corp.
|
Sep 24, 2019 11:00AM
|
|
Re: https://scr.zacks.co...
|
2
|
Zenith Epigenetics
|
May 06, 2020 09:35AM
|
|
Re: Exempt
|
2
|
Resverlogix Corp.
|
Mar 24, 2021 04:03PM
|
|
Re: Flavoured HIV drug for children to be rolled out in Africa?
|
2
|
Resverlogix Corp.
|
Dec 02, 2020 02:33PM
|
|
Re: RESVERLOGIX ANNOUNCES WARRANT EXERCISE INCENTIVE PROGRAM
|
2
|
Resverlogix Corp.
|
Nov 25, 2019 06:24PM
|
|
Re: Eastern
|
2
|
Resverlogix Corp.
|
Aug 13, 2019 08:48AM
|
